|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
CA1080712A
(en)
*
|
1976-09-22 |
1980-07-01 |
Jay D. Albright |
Hypotensive agents
|
|
US4230705A
(en)
*
|
1976-09-22 |
1980-10-28 |
American Cyanamid Company |
6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
|
|
US4112095A
(en)
*
|
1976-10-07 |
1978-09-05 |
American Cyanamid Company |
6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents
|
|
US4242515A
(en)
|
1979-03-28 |
1980-12-30 |
American Cyanamid Company |
Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
US5364620A
(en)
|
1983-12-22 |
1994-11-15 |
Elan Corporation, Plc |
Controlled absorption diltiazem formulation for once daily administration
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
US4902514A
(en)
|
1988-07-21 |
1990-02-20 |
Alza Corporation |
Dosage form for administering nilvadipine for treating cardiovascular symptoms
|
|
GB9507348D0
(en)
*
|
1995-04-08 |
1995-05-31 |
Knoll Ag |
Therapeutic agents
|
|
EP1301511A2
(en)
|
2000-07-14 |
2003-04-16 |
Bristol-Myers Squibb Pharma Company |
IMIDAZO 1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
|
|
JP4898445B2
(ja)
*
|
2003-05-29 |
2012-03-14 |
シャイア エルエルシー |
乱用抵抗性アンフェタミン化合物類
|
|
WO2005077953A1
(ja)
*
|
2004-02-18 |
2005-08-25 |
Banyu Pharmaceutical Co., Ltd. |
含窒素縮合へテロ芳香環誘導体
|
|
WO2006061428A2
(en)
*
|
2004-12-10 |
2006-06-15 |
Universität Zürich |
Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain
|
|
US20100088778A1
(en)
|
2005-06-16 |
2010-04-08 |
John Charles Mulley |
Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene
|
|
RS55630B1
(sr)
|
2005-12-21 |
2017-06-30 |
Janssen Pharmaceutica Nv |
Triazolopiridazini kao modulatori tirozin kinaze
|
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
PE20121506A1
(es)
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
Compuestos triazolopiridinas como inhibidores de c-met
|
|
FR2915198B1
(fr)
|
2007-04-18 |
2009-12-18 |
Sanofi Aventis |
Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
|
|
BRPI0908428A2
(pt)
|
2008-02-06 |
2015-12-08 |
Gilead Sciences Inc |
uso de ranozalina para tratar a dor.
|
|
WO2010053757A1
(en)
|
2008-10-29 |
2010-05-14 |
Gilead Palo Alto, Inc. |
2 -oxoquinoxalin blockers of the late sodium channel
|
|
WO2010074807A1
(en)
|
2008-10-30 |
2010-07-01 |
Gilead Palo Alto, Inc. |
3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
|
|
US20100125091A1
(en)
|
2008-11-14 |
2010-05-20 |
Gilead Palo Alto, Inc. |
Substituted heterocyclic compounds as ion channel modulators
|
|
AU2009330821B2
(en)
|
2008-12-24 |
2015-06-11 |
Bial - Portela & Ca, S.A. |
Pharmaceutical compounds
|
|
JP5340798B2
(ja)
|
2009-05-07 |
2013-11-13 |
タイガースポリマー株式会社 |
地中埋設管の製造方法
|
|
HRP20131122T1
(hr)
|
2009-05-12 |
2013-12-20 |
Janssen Pharmaceuticals, Inc. |
Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
|
|
HUE034911T2
(hu)
*
|
2009-07-27 |
2018-03-28 |
Gilead Sciences Inc |
Fúzionált heterociklusos vegyületek mint ioncsatorna modulátorok
|
|
WO2011056985A2
(en)
|
2009-11-04 |
2011-05-12 |
Gilead Sciences, Inc. |
Substituted heterocyclic compounds
|
|
FR2953520B1
(fr)
|
2009-12-04 |
2011-11-25 |
Sanofi Aventis |
Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique
|
|
EP2588107A1
(en)
|
2010-07-01 |
2013-05-08 |
Takeda Pharmaceutical Company Limited |
COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
|
|
EP2588197B1
(en)
|
2010-07-02 |
2014-11-05 |
Gilead Sciences, Inc. |
Fused heterocyclic compounds as ion channel modulators
|
|
WO2012065297A1
(en)
|
2010-11-16 |
2012-05-24 |
Impact Therapeutics, Inc. |
3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
|
|
US9139576B2
(en)
|
2011-05-03 |
2015-09-22 |
Merck Sharp & Dohme Corp. |
Aminomethyl biaryl benzotriazole derivatives
|
|
WO2012154760A1
(en)
|
2011-05-10 |
2012-11-15 |
Gilead Sciences, Inc. |
Fused heterocyclic compounds as sodium channel modulators
|
|
NO3175985T3
(enExample)
|
2011-07-01 |
2018-04-28 |
|
|
|
WO2013043925A1
(en)
|
2011-09-21 |
2013-03-28 |
Gilead Sciences, Inc. |
Sodium channel blockers reduce glucagon secretion
|
|
EP2760866B1
(en)
|
2011-09-27 |
2017-12-13 |
Genfit |
Derivatives of 6-substituted triazolopyridazines as rev-erb agonists
|
|
CN103122000B
(zh)
*
|
2012-09-03 |
2013-12-25 |
中美冠科生物技术（太仓）有限公司 |
用作抗肿瘤药物的高选择性的c-Met激酶抑制剂
|
|
TWI574962B
(zh)
*
|
2012-11-14 |
2017-03-21 |
加拓科學公司 |
作爲ｐｉ３激酶調節劑的芳雜環化合物及其使用方法和用途
|
|
WO2014100764A2
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Methods of inhibiting prmt5
|
|
US20140329755A1
(en)
|
2013-05-01 |
2014-11-06 |
Gilead Sciences, Inc. |
Combination therapy for the treatment of arrhythmias or heart failure
|
|
KR102307566B1
(ko)
|
2013-06-21 |
2021-10-05 |
제니쓰 에피제네틱스 리미티드 |
신규한 바이사이클릭 브로모도메인 억제제
|
|
DK3035926T3
(da)
|
2013-08-19 |
2020-08-31 |
Univ California |
Forbindelser og fremgangsmåder til behandling af en epilepsilidelse
|
|
GB201321740D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
WO2015095370A1
(en)
|
2013-12-19 |
2015-06-25 |
Gilead Sciences, Inc. |
Fused heterocyclic compounds as ion channel modulators
|
|
WO2015157955A1
(en)
|
2014-04-17 |
2015-10-22 |
Abbvie Inc. |
Heterocyclic btk inhibit ors
|
|
US10030026B2
(en)
*
|
2014-06-04 |
2018-07-24 |
Rugen Holdings (Cayman) Limited |
Difluoroethylpyridine derivatives as NR2B NMDA receptor antagonists
|
|
EP3159366B1
(en)
|
2014-06-20 |
2020-04-08 |
Mitsubishi Chemical Corporation |
Polycarbonatediol, method for producing same, and polyurethane produced using same
|
|
TWI713455B
(zh)
|
2014-06-25 |
2020-12-21 |
美商伊凡克特治療公司 |
ＭｎＫ抑制劑及其相關方法
|
|
PE20161476A1
(es)
|
2014-06-26 |
2017-01-07 |
Hoffmann La Roche |
Derivados de indolin-2-ona o pirrolo-piridin-2-ona
|
|
JP2017001991A
(ja)
|
2015-06-11 |
2017-01-05 |
大日本住友製薬株式会社 |
新規ベンズオキサゾロン化合物
|
|
US11352328B2
(en)
|
2016-07-12 |
2022-06-07 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus
|
|
TW201819376A
(zh)
|
2016-10-06 |
2018-06-01 |
比利時商健生藥品公司 |
經取代之１Ｈ－咪唑並［４，５－ｂ］吡啶－２（３Ｈ）－酮及其作為ＧＬＵＮ２Ｂ受體調節劑之用途
|
|
CA3281817A1
(en)
|
2016-11-28 |
2026-03-02 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
WO2018098491A1
(en)
|
2016-11-28 |
2018-05-31 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
WO2018098500A1
(en)
|
2016-11-28 |
2018-05-31 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
US11492345B2
(en)
|
2017-02-13 |
2022-11-08 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
WO2018187480A1
(en)
|
2017-04-04 |
2018-10-11 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
US11278535B2
(en)
|
2017-08-15 |
2022-03-22 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
IL309843B2
(en)
|
2018-05-30 |
2026-05-01 |
Praxis Prec Medicines Inc |
History of [4,2,1]triazolo[3,4-a]pyridines and their use as sodium ion channel modulators
|
|
EA202092908A1
(ru)
|
2018-09-28 |
2021-05-14 |
Праксис Пресижн Медсинз, Инк. |
Модуляторы ионных каналов
|
|
US11773099B2
(en)
|
2019-05-28 |
2023-10-03 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
US11505554B2
(en)
|
2019-05-31 |
2022-11-22 |
Praxis Precision Medicines, Inc. |
Substituted pyridines as ion channel modulators
|
|
US11279700B2
(en)
|
2019-05-31 |
2022-03-22 |
Praxis Precision Medicines, Inc. |
Ion channel modulators
|
|
US11767325B2
(en)
|
2019-11-26 |
2023-09-26 |
Praxis Precision Medicines, Inc. |
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
|
|
JP2023503343A
(ja)
|
2019-11-26 |
2023-01-27 |
プラクシス プレシジョン メディシンズ， インコーポレイテッド |
イオンチャネルモジュレーター
|
|
PE20221280A1
(es)
|
2019-11-27 |
2022-09-05 |
Praxis Prec Medicines Inc |
Formulaciones de moduladores de canales ionicos y metodos de preparacion y uso de moduladores de canales ionicos
|